EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Ubiquitination network in the type I IFN‐induced antiviral signaling pathway

Qian Zhao, Renxia Zhang, Caixia Qiao, Ying Miao, Yukang Yuan, Hui Zheng iD

European Journal of Immunology · 2023

DOI: 10.1002/eji.202350384 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, 2023. Verfasst von Qian Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Antiviral Agents, Interferon Type I. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 196 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type I IFN (IFN‐I) is the body's first line of defense against pathogen infection. IFN‐I can induce cellular antiviral responses and therefore plays a key role in driving antiviral innate and adaptive immunity. Canonical IFN‐I signaling activates the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway, which induces the expression of IFN‐stimulated genes and eventually establishes a complex antiviral state in the cells. Ubiquitin is a ubiquitous cellular molecule for protein modifications, and the ubiquitination modifications of protein have been recognized as one of the key modifications that regulate protein levels and/or signaling activation. Despite great advances in understanding the ubiquitination regulation of many signaling pathways, the mechanisms by which protein ubiquitination regulates IFN‐I‐induced antiviral signaling have not been explored until very recently. This review details the current understanding of the regulatory network of ubiquitination that critically controls the IFN‐I‐induced antiviral signaling pathway from three main levels, including IFN‐I receptors, IFN‐I‐induced cascade signals, and effector IFN‐stimulated genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsInterferon Type IImmunity, InnateSignal TransductionUbiquitination

Stichwörter der Autor:innen

Antiviral signalingIFN-stimulated genesInnate immunityType I IFNUbiquitin

Substanzen

Antiviral AgentsInterferon Type I

Autor:innen und Institutionen

  • International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.
  • Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, China.

ORCID-Profile: Hui Zheng

Förderung

  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

Zhao, Q., Zhang, R., Qiao, C., Miao, Y., Yuan, Y., & Zheng, H. (2023). Ubiquitination network in the type I IFN‐induced antiviral signaling pathway. European Journal of Immunology. https://doi.org/10.1002/eji.202350384

Vancouver

Zhao Q, Zhang R, Qiao C, Miao Y, Yuan Y, Zheng H. Ubiquitination network in the type I IFN‐induced antiviral signaling pathway. European Journal of Immunology. 2023. doi:10.1002/eji.202350384

BibTeX
@article{Zhao2023,
  author = {Zhao, Qian and Zhang, Renxia and Qiao, Caixia and Miao, Ying and Yuan, Yukang and Zheng, Hui},
  title = {Ubiquitination network in the type I IFN‐induced antiviral signaling pathway},
  journal = {European Journal of Immunology},
  year = {2023},
  doi = {10.1002/eji.202350384}
}
Kostenlos starten →